While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

A research team from the University of Oklahoma has pioneered a method that could accelerate drug discovery and reduce pharmaceutical development costs. Their work, published in the Journal of the ...

Tariffs, compounded by existing drug shortages, could increase costs for medications in the U.S. Many, or all, of the products featured on this page are from our advertising partners who ...

All these factors contribute to an efficient development process, lowering long-term costs while enhancing user satisfaction. Additionally, conducting UX testing during various stages of development ...

With US President Donald Trump leaning towards implementing additional tariffs on the pharmaceutical sector, there is potential to disrupt drug development costs and drug prices, with any tariffs ...

With US President Donald Trump leaning towards implementing additional tariffs on the pharmaceutical sector, there is potential to disrupt drug development costs and drug prices, with any tariffs ...

"I am excited to welcome Mark to the team. He has a comprehensive command of all phases of drug development and a track record that includes multiple drug approvals. Mark's leadership will be ...

"I am excited to welcome Mark to the team. He has a comprehensive command of all phases of drug development and a track record that includes multiple drug approvals. Mark's leadership will be ...

The Ernst & Young report also said the tariffs on drug ingredients would cause U.S. manufacturing costs to rise by 4.1%. Around 25% of pharmaceutical production — $101 billion in 2023 — is ...

Confusion over the U.S. Food and Drug Administration delay in granting ... a step that would cost the company tens of millions of dollars and delay by months if not longer full approval of the ...

A report suggests that a proposed tariff could significantly increase medicine costs in America. The analysis estimates a potential rise of nearly 51 billion dollars annually. This could lead to a ...